Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors
Abstract Blood pressure measurements form a critical component of adverse event monitoring for tyrosine kinase inhibitors, but might also serve as a biomarker for dose titrations. This study explored the impact of various sources of within‐individual variation on blood pressure readings to improve m...
Hauptverfasser: | , , , , |
---|---|
Format: | Artikel |
Sprache: | English |
Veröffentlicht: |
Wiley
2023-01-01
|
Schriftenreihe: | Clinical and Translational Science |
Online Zugang: | https://doi.org/10.1111/cts.13423 |